|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||30.62 - 31.58|
|52 Week Range||10.52 - 38.00|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||42.86|
Thailand's largest lender Siam Commercial Bank Pcl (SCB) announced a partnership with e-commerce and game developer Sea Ltd's Thai operations to provide payments and lending services as it seeks to increase revenues from digital banking. Siam Commercial will provide lending services to small businesses on Singapore-based Sea's platforms, the bank's president, Apiphan Charoenanusorn. Sea's AirPay customers will also be able to pay bills via SCB's apps, he said.
The company announced its treatment for hepatitis B is being investigated in Janssen Pharmaceuticals’ Phase 2b study. The stock has been in a beautiful up-channel this year, doubling since the start of May, and the rising channel top points to $39 next. Luckin Coffee Inc. (LK) popped $1.55, or 8%, to $21.03 on 3.6 million shares on no news reported by the company.
(Bloomberg) -- Amazon.com Inc. is in talks to make an investment in Indonesian ride-hailing giant Gojek, people familiar with the negotiations said, a move that could bolster the U.S. company’s presence in Southeast Asia.Amazon is one of the firms that have been negotiating with Gojek to join its ongoing funding round, according to the people, who asked not to be identified as the discussions are private. Under one scenario that has been considered, Amazon may make a meaningful investment for a slice of Indonesia’s most valuable startup, said one of the people. The talks may still fall apart or the terms may change.A Gojek representative declined to comment. Amazon couldn’t immediately be reached for comment outside of normal business hours. The Wall Street Journal earlier reported on the discussions.The move could mark Amazon’s most significant investment in Indonesia, one of the last frontiers of e-commerce. The Seattle-based retail giant took its first step into the region in 2017 when it entered Singapore with Amazon Prime Now. But in Indonesia, by far the region’s biggest and most promising market with 260 million people, it has no presence.By contrast, Chinese tech titans have made inroads into the region recently. Alibaba Group Holding Ltd. spent billions of dollars to acquire online shopping company Lazada Group and invested in homegrown Indonesian e-commerce companies Tokopedia PT and Bukalapak. Tencent Holdings Ltd. has backed Sea Ltd., whose mobile shopping unit Shopee is battling fiercely with Lazada.Gojek debuted its app for hailing motorbike taxis in Jakarta in 2015. Since then, the company has evolved into a “super app” -- part ride-sharing service, part food-delivery business and part digital-wallet provider. It also offers a dozen other on-demand services such as booking a cleaner and medicine delivery.As part of the ongoing Series F funding round, Gojek -- valued at $10 billion, according to CB Insights -- has secured investments from Visa Inc., Thailand’s Siam Commercial Bank Plc, Mitsubishi Motors Corp., Mitsubishi Corp. and Mitsubishi UFJ Lease & Finance Co. this year. The terms of those deals were not disclosed.Visa Invests in Go-Jek for Digital Payments in Southeast AsiaThose investments added to more than $1 billion Gojek secured in a previous funding round earlier this year.\--With assistance from Manuel Baigorri.To contact the reporters on this story: Yoolim Lee in Singapore at firstname.lastname@example.org;Crystal Tse in Hong Kong at email@example.comTo contact the editors responsible for this story: Peter Elstrom at firstname.lastname@example.org, ;Fion Li at email@example.com, Molly Schuetz, Robin AjelloFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. iBio (NYSE: IBIO ) shares were down 14% to ...
The Zacks Analyst Blog Highlights: Sea, Target, 1-800-FLOWERS.COM, Burlington and Cooper Companies
The decline in Sea Ltd.'s stock price came even as the company reported a big jump in revenue and earnings generated by its marquee digital entertainment unit, the developer of 'Free Fire,' it's Fortnite-like video game.
SINGAPORE , Aug. 20, 2019 /PRNewswire/ -- Sea Limited (NYSE: SE) ("Sea" or the "Company") today announced its financial results for the quarter ended June 30, 2019 . Second Quarter ...
NEW YORK, NY / ACCESSWIRE / August 19, 2019, 2018 / Sea Ltd. (Singapore) (NYSE: SE ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on August 19, 2019 at 7:30 ...
Investment company MayTech Global Investments, LLC (Current Portfolio) buys Sea, sells CenturyLink Inc, Exxon Mobil Corp, Netflix Inc, Berkshire Hathaway Inc during the 3-months ended 2019Q2, according to the most recent filings of the investment company, MayTech Global Investments, LLC. Continue reading...
SINGAPORE , July 31, 2019 /PRNewswire/ -- Sea Limited (NYSE: SE) ("Sea" or the "Company") plans to announce its second quarter 2019 results before the U.S. market opens on August 20, ...
Nicholas Nash, the former president of Singapore-based online gaming and e-commerce company Sea Ltd, has launched a private equity firm - Asia Partners - to invest in Southeast Asian technology start-ups. Asia Partners' four other co-founders include Oliver Rippel, a former senior executive of South Africa's Naspers, and Pitra Ciputra Harun, who was previously with Indonesian e-commerce company Bukalapak, according to the company statement on Friday. The private equity firm aims to make investments of between $20 million and $100 million.
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]
Despite the market's drubbing since late April, stocks are still up for the year. Some stocks, in fact, are still well up since the end of 2018. The best stocks for 2019 so far have been buoyed by strong backstories, impressive results or just an inordinate amount of rampant speculation.Regardless of the reason, that raw strength is worth a closer look. These big winners may be in the midst of unstoppable rallies, making these names some of the best stocks to buy for what looks like a rather rough summer. Or it's just as possible these big rallies have set up equally big selloffs, and profit-takers are ready plow in. * 6 Big Dividend Stocks to Buy as Yields Plunge While these may be the best stocks of 2019 so far in terms of performance, notice how few of them are mainstream or household names. Maybe being off the radar -- or working on an unbeatable business -- is the key to shrugging off marketwide lethargy.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Array Biopharma (ARRY)Source: Shutterstock YTD Gain: 97%Array Biopharma (NASDAQ:ARRY) has been the beneficiary of not one but two waves of great news this year, fueling two incredible surges. In January shares rallied on the heels of a successful phase 3 trial of one of its colon cancer therapies. Then, in May, ARRY stock popped again when the same combination therapy showed tremendous promise as a treatment for advanced melanoma.Though Array Biopharma is growing the top line at a strong double-digit rate, it's at a stage where the bigger the company gets, the more money it loses. It's going to need to lot more scale to get into the black, and that may not happen for a long while.Though analysts love ARRY for its story and potential, the current price is already very near the consensus target of $28.80. And the pros haven't seemed interested in upping that target. Sinclair Broadcast Group (SBGI)Source: Flash.pro via Flickr (modified)YTD Gain: 104%To be fair, shares of Sinclair Broadcast Group (NASDAQ:SBGI) started the new year out with something of an advantage for this list. SBGI has spent four straight years spinning its wheels, with SBGI stock making no net progress between the end of 2013 and late 2018. * 7 Stocks to Sell Impacted by the Mexican Tariffs The company may be one of the few traditional television outfits that's positioned to survive the cord-cutting phenomenon though. Sinclair is the company that bought most of the regional sports networks Walt Disney (NYSE:DIS) owned after it acquired Fox. It rallied leading into the news on speculation that it would happen, but continued to rally after the announcement on chatter that it was already thinking about distribution deals through non-traditional venues like Amazon.com (NASDAQ:AMZN). Iovance Biotherapeutics (IOVA)Source: (C)iStock.com/AlexRaths YTD Gain: 104%Despite being one of the best stocks of 2019 when looking at returns, biotech company Iovance Biotherapeutics (NASDAQ:IOVA) is pre-profit. In fact, it's pre-revenue. A handful of investors are enthused about its pipeline though, and particularly Lifileucel as a treatment for melanoma. It's in late-stage trials right now and looking very promising.At the same time, a recent update on its investigator-sponsored trial of LN-145 as a treatment of cervical cancer has also been well received.Of that testing, Emese Zsiros, M.D., Ph.D. and observer of the trial in question commented "The observation in the study of LN-145 that median DOR has not yet been reached at a median of 7.4 months following treatment provides evidence that this therapy could provide a clinically meaningful improvement over currently available options for patients with advanced cervical cancer."For the first time ever, Iovance Biotherapeutics is nearing a developmental endzone… a couple of endzones, actually. Guardant Health (GH)Source: Shutterstock YTD Gain: 108%Guardant Health (NASDAQ:GH) is not just one of this year's biggest winners and best stocks. It's also been one of the hottest IPOs of late. Only going public in early October, shares are already up an incredible 300%, and have gained more than 100% since the end of calendar 2018.Guardant Health is a developer of a handful of highly-focused oncology diagnostics tests. By digging deeper into genomic information, the company identifies which cancer treatment regimen would be most effective for a particular patient. Its technology has even proven useful for pharmaceutical developers looking to pinpoint genomic data that leads to better drug-testing outcomes. * 9 Trade War Stocks to Sell on U.S.-China Deal News The organization isn't profitable yet, but its strong revenue growth pace is leading to smaller and smaller losses that put Guardant Health on a path to profits in the foreseeable future. Mirati Therapeutics (MRTX)Source: Shutterstock YTD Gain: 110%Coming into the year, Mirati Therapeutics (NASDAQ:MRTX) was already on a bullish rampage more than doubling in 2018 thanks to progress with its pipeline.The lead drug is sitravatinib -- an immuno-oncology agent that, when used in conjunction with an anti-PD-1 checkpoint inhibitor drug Opdivo, shows promise as a second-line treatment for non-small-cell lung cancer. That phase 3 trial should be starting soon. The drug appeared to crash and burn given October's updated data, but another round of testing could still salvage that work.In the meantime, MRTX jumped more than 30% on Monday after rival drug company Amgen (NASDAQ:AMGN) offered an update on a drug similar to sitravatinib that validates sitravatinib itself.While encouraging, the total advance since mid-2017 looks and feels overextended. Though its been one of the best stocks of 2019 so far, I don't think the back half of the year holds much promise. Avalara (AVLR)Source: 401(k) 2012 via FlickrYTD Gain: 110%Avalara (NYSE:AVLR) is a software company with a good-sized suite of product, but its claim to fame and flagship is a sales tax-calculation tool that's become enormously important now that more and more states are enforcing the collection of sales tax on interstate e-commerce transactions.Sales growth hasn't been a problem. This year's projected top-line improvement of 28% extends a long-standing streak, and the pros are calling for comparable revenue growth this year. Where Avalara falls short is on the earnings front. Despite strong sales growth for years now, the company remains in the red… but not for much longer. If all goes as planned, this year's estimated loss of 18 cents per share following last year's loss of 67 cents should swing to a profit of eight cents per share. * 7 Stocks to Sell in June With operating earnings in sight, AVLR is up 110% so far this year, making it one of 2019's very best stocks to own. Snap (SNAP)Source: Shutterstock YTD Gain: 112%Shares of Snap (NYSE:SNAP) are up big time this year, but it's a gain with a major asterisk. That is, the triple-digit gain since late last year is a reclamation of the massive amount of ground SNAP stock lost in 2018. Even with that bullish move, SNAP stock is still only trading at about two-thirds of its early 2017 IPO price.Still, credit has to be given where it's due. The rebound rally was inspired by last quarter's smaller-than-expected loss and renewed progress in the number of daily users logging into the app.That said, more user growth could be in the cards now that the company recognizes simply have a communication platform isn't enough. It's starting to innovate in a big way, with the most recent idea being working directly with record labels to improve how music can be used in the app. Sea Limited (SE)Source: Shutterstock YTD Gain: 147%Sea Limited (NYSE:SE) offers several different types of digital entertainment to eastern Asian consumers -- particularly outside of China. But mobile and PC games along with eSports and e-commerce services are its core operations. Sea is best known, however, for its mobile wallet app called AirPay.It's been growing like crazy too. Though still booking losses (and likely to continue doing so for a few more years), sales are estimated to rise by almost 100% this year, and grow another 40% next year. The company has found its place, and stride. * 6 Big Dividend Stocks to Buy as Yields Plunge Nevertheless, this might be a rally to be wary of. While analysts will often up their consensus target as a stock rises, the current price near $28 is above a seemingly stagnant price target of just under $27. Spark Therapeutics (ONCE)Source: Shutterstock YTD Gain: 178%Take the huge 178% gain Spark Therapeutics (NASDAQ:ONCE) has dished out this year with a grain of salt. It all almost happened in one shot. In late February ONCE stock soared on the heels of news that drug company Roche (OTCMKTS:RHHBY) had made a very generous acquisition offer.The deal hasn't been consummated yet, and the FTC still needs to give it the green light. But, Roche says it expects the offer to be finalized and accepted before the end of the month.While it's unlikely the intended pairing will be derailed at this point, on the off chance it does, know that Roche's interest wasn't just Spark's Luxterna -- though it's the FDA's first-ever gene therapy treatment for a retinal disease that often leads to blindness. But ONCE's underlying gene therapy science has value well beyond that one application. Roku (ROKU)Source: Roku YTD Gain: 193%Finally, this year's biggest winner has been Roku (NASDAQ:ROKU), up almost 200% in just a little over five months.Like several other of the oversized gains we've seen since the end of 2018, Roku had the benefit of coming out of an oversized pullback during the last few months of last year. Nevertheless, the stock's earned every bit of its current price near $90.Roku, of course, is the name behind what's become the world's most popular streaming video receiver, dethroning several other (and bigger) consumer-tech companies that arguably should have been able to keep the young company at bay. * 7 Stocks to Sell Impacted by the Mexican Tariffs Whatever the case, this year's big move coincides with the company's discovery of several winning formulas and initiatives. Namely, Roku has figured out it can make even more money by selling ad space through its devices than just selling devices themselves. In that the latter fuels the former though, the pros are calling for an amazing 41% increase in this year's sales to be followed by 33% growth next year.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Stocks to Sell Impacted by the Mexican Tariffs * 6 Big Dividend Stocks to Buy as Yields Plunge * The 10 Biggest Announcements From Apple WWDC 2019 Compare Brokers The post The 10 Best Stocks for 2019 -- So Far appeared first on InvestorPlace.
SHENZHEN, China/SHANGHAI, May 28 (Reuters) - When Tencent Holdings Ltd made its first big foray overseas with an adaptation of its blockbuster mobile game "Honour of Kings" in the summer of 2017, executives thought they had a sure-fire success on their hands. The multi-player role-playing game, in which players hack and slash their way through battle arenas, had 55 million daily active users in China and was raking in roughly $145 million a month, making it the company's top grossing game. Tencent has now all but written off its original plans for "Arena of Valor" and disbanded the game's marketing team for Europe and the United States, two company sources with direct knowledge of the matter said.